Keywords: مهار کننده پمپ پروتون; CI; confidence interval; H2RA; histamine-2 receptor antagonist; PPI; proton pump inhibitor; SIR; standardised incidence ratio; Gastrointestinal neoplasms; Esophageal neoplasms; Gastroesophageal reflux; Gastric acid; Proton pump inhibitors;
مقالات ISI مهار کننده پمپ پروتون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده پمپ پروتون; H.pylori; Helicobactor pylori; PPI; Proton pump inhibitor; TBRI; Theodor Bilharz Research Institute; DNA; Deoxy-ribonucleic acid; PCR; Polymerase chain reaction; 16S rRNA; 16 S ribosomal ribonucleic acid; dNTPs; Deoxynucleotide Triphosphates; SPSS; Statis
Keywords: مهار کننده پمپ پروتون; Cirrhosis; Hepatic encephalopathy; Proton pump inhibitor; Mortality;
Keywords: مهار کننده پمپ پروتون; Drugs; Hypomagnesemia; Hypermagnesemia; Proton pump inhibitor; CKD;
Keywords: مهار کننده پمپ پروتون; AKI; acute kidney injury; BMD; bone mineral density; CAP; community-acquired pneumonia; CDI; Clostridium difficile infection; CKD; chronic kidney disease; FDA; Food and Drug Administration; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; PPI;
Keywords: مهار کننده پمپ پروتون; GERD; Laryngopharyngeal reflux (LPR); Nonallergic rhinitis; Proton pump inhibitors; H2 blocker; Head-of-bed elevation; Reflux Symptom Index score; AUC; area under the curve; GERD; gastroesophageal reflux disease; LPR; laryngopharyngeal reflux; PPI; proton
Keywords: مهار کننده پمپ پروتون; Endothelin; Liver cirrhosis; Nitric oxide; Portal hypertension; Proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; Proton pump inhibitor; Myocardial infarct; Cardiovascular disease; ADMA; Nitric oxide; Mortality;
Keywords: مهار کننده پمپ پروتون; EoE; eosinophilic esophagitis; PPI; proton pump inhibitor; UNC; University of North Carolina;
Keywords: مهار کننده پمپ پروتون; Laryngopharyngeal reflux; Geriatric; Laryngitis; Proton pump inhibitor; Treatment;
Keywords: مهار کننده پمپ پروتون; Environment; early life; microbiome; epigenetics; gene-environment interaction; alpha-gal; Galactose-alpha,1,3-galactose; aOR; Adjusted odds ratio; CTD; Connective tissue disorder; EoE; Eosinophilic esophagitis; HSV; Herpes simplex virus; NSAID; Nonsteroi
Keywords: مهار کننده پمپ پروتون; CI; confidence interval; NSAID; nonsteroidal anti-inflammatory drug; PPI; proton pump inhibitor; RBC; red blood cell; RR; relative risk;
Keywords: مهار کننده پمپ پروتون; Erosive Esophagitis; Barrett's Esophagus; Esophageal Stricture; EoE; eosinophilic esophagitis; GERD; gastroesophageal reflux disease; PPI; proton pump inhibitor; PPI-REE; PPI-responsive esophageal eosinophilia;
Keywords: مهار کننده پمپ پروتون; GEJ; gastroesophageal junction; GER; gastroesophageal reflux; GERD; gastroesophageal reflux disease; PPI; proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; ARDS; acute respiratory distress syndrome; BALF; bronchoalveolar fluid; CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; EGJ; esophagogastric junction; GER; gastroesophageal reflux; GERD; gastroesophageal reflux disease; IPF; idiopathic p
Keywords: مهار کننده پمپ پروتون; Proton pump inhibitor; gastroesophageal reflux disease; adverse events; safety;
Keywords: مهار کننده پمپ پروتون; GERD; gastroesophageal reflux disease; NERD; non-erosive disease; ERD; erosive disease; LES; lower esophageal sphincter; PPI; proton pump inhibitor; H2RA; histamine receptor antagonists; ATPase; adenosine 5â²triphosphatase; EE; erosive esophagitis; NNT;
Keywords: مهار کننده پمپ پروتون; Esophageal Motility; Esophageal Sensitivity; Acid Exposure; Transient Lower Esophageal Sphincter Relaxations; Hiatal Hernia; EGJ; esophagogastric junction; GERD; gastroesophageal reflux disease; LES; lower esophageal sphincter; NERD; nonerosive reflux dis
Keywords: مهار کننده پمپ پروتون; Involuntary Diaphragmatic Contraction; Acid Reflux; Controlled Trial; Speech Therapy; Supragastric Belching; Diaphragmatic Breathing; PPI Refractory; DB; diaphragmatic breathing; GB; gastric belching; GERD; gastroesophageal reflux disease; HADS; Hospital
Keywords: مهار کننده پمپ پروتون; GERD; Mucosal Impedance; Reflux Monitoring; DGER; duodenogastroesophageal reflux; EoE; eosinophilic esophagitis; GERD; gastroesophageal reflux disease; MI; mucosal impedance; NBI; narrow-band imaging; NERD; nonerosive reflux disease; PPI; proton pump inhi
Keywords: مهار کننده پمپ پروتون; Eosinophilic Esophagitis; Esophagitis; Esophagus; DIS; dilation of intercellular space; EoE; eosinophilic esophagitis; EREFS; edema, rings, exudates, furrows, and strictures; GERD; gastroesophageal reflux disease; HPF; high power field; IL; interleukin; P
Keywords: مهار کننده پمپ پروتون; Incidence; Prevalence; Progression; Fibrosis; CI; confidence interval; EoE; eosinophilic esophagitis; PPI; proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; STING Study; Stomach; Clinical Trial; Comparison; CI; confidence interval; ICU; intensive care unit; IV; intravenous; OTSC; over-the-scope clip; PPI; proton pump inhibitor; RCT; randomized controlled trial; TAE; transarterial embolization; TTSC; through-t
Keywords: مهار کننده پمپ پروتون; Epidemiology; Reflux Treatment; Cardiovascular Disease; Drug; BMI; body mass index; CI; confidence interval; GERD; gastroesophageal reflux disease; GI; gastrointestinal; H2RA; histamine-2 receptor antagonist; HPFS; Health Professionals Follow-up Study; HR
Keywords: مهار کننده پمپ پروتون; CBC; complete blood count; CDI; Clostridium difficile infection; EN; enteral nutrition; GI; gastrointestinal; GRV; gastric residual volume; H2RB; histamine-2 receptor blocker; ICU; intensive care unit; INR; international normalized ratio; IQR; interquarti
Keywords: مهار کننده پمپ پروتون; Gastric ulcer; Non-steroidal anti-inflammatory drugs; Proton pump inhibitor; Polydeoxyribonucleotide; Combination therapy;
Keywords: مهار کننده پمپ پروتون; Gastrointestinal Hemorrhage; Endoscopy; Outcome; CI; confidence interval; ED; Emergency Department; GBS; Glasgow-Blatchford score; Hb; hemoglobin; OR; odds ratio; PPI; proton pump inhibitor; pRBC; packed red blood cell; UGIB; upper gastrointestinal blee
Keywords: مهار کننده پمپ پروتون; PIB; Progression in Barrett's Esophagus score; Multi-Center Trial; Esophageal Cancer; BE; Barrett's esophagus; BEST; Barrett's Esophagus Study; CI; confidence interval; EAC; esophageal adenocarcinoma; HGD; high-grade dysplasia; HR; hazard ratio; LGD
Keywords: مهار کننده پمپ پروتون; Allergy; antibiotics; acid suppressant; breast-feeding; cesarean delivery; early-life factors; environment; eosinophilic esophagitis; furred pet; neonatal intensive care unit; acid-suppressive agents; aOR; Adjusted odds ratio; CCHMC; Cincinnati Children's
Keywords: مهار کننده پمپ پروتون; ATC; anatomic therapeutic chemical classification; CI; confidence interval; HR; hazard ratio; ICD-10; International Classification of Diseases, 10th version; PPI; proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; Eosinophilic esophagitis; diet; milk; wheat; six-food elimination; DSS; Dysphagia Symptom Score; EoE; Eosinophilic esophagitis; FFGED; Four-food-group elimination diet; hpf; High-power field; IQR; Interquartile range; PPI; Proton pump inhibitor; SFGED; Si
Keywords: مهار کننده پمپ پروتون; MOF; major osteoporotic fracture; DVO; Dachverband Osteologie (German Osteology Society); SVLFG; Sozialversicherung für Landwirtschaft Forsten und Gartenbau (Social insurance for agriculture forestry and horticulture); ICD-10-GM; 10th revision of the Int
Keywords: مهار کننده پمپ پروتون; Acid-Suppressive Therapy; Heart Disease; Pharmacoepidemiology; Comparative Safety; ADMA; asymmetrical dimethylarginine; CI; confidence interval; FDAs; Food and Drug Administration; GERD; gastroesophageal reflux disease; H2RA; histamine-2 receptor antagoni
Keywords: مهار کننده پمپ پروتون; chronic cough: interstitial lung disease; refractory; sarcoidosis; scleroderma; treatment; unexplained; CINAHL; Cumulative Index of Nursing and Allied Health Literature; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; LCQ; Leicester Co
Keywords: مهار کننده پمپ پروتون; Laryngopharyngeal reflux; Head and neck cancer; Radiation; Mucositis; Proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; Nursing home; Proton pump inhibitor; Indication; Elderly;
Keywords: مهار کننده پمپ پروتون; Helicobacter pylori; Gastritis; Gastric ulcers; Triple therapy; Proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; BE; Barrett's esophagus; EAC; esophageal adenocarcinoma; EoE; eosinophilic esophagitis; ESD; endoscopic submucosal dissection; POEM; peroral endoscopic myotomy; PPI; proton pump inhibitor; RFA; radiofrequency ablation; VCE; video capsule endoscopy;
Keywords: مهار کننده پمپ پروتون; ALOX15; CCL26; Eosinophilic esophagitis; Gene expression; Proton pump inhibitor; RTNLB;
Keywords: مهار کننده پمپ پروتون; Rhinosinusitis; Laryngopharyngeal reflux; Gastroesophageal reflux disease; pH-metry; Proton pump inhibitor; Rinossinusite; Refluxo laringofarÃngeo; Doença do refluxo gastroesofágico; pHmetria; Inibidor de bomba de prótons;
Keywords: مهار کننده پمپ پروتون; Impedance; gastroesophageal reflux; gastroparesis; proton pump inhibitor; fundoplication;
Keywords: مهار کننده پمپ پروتون; antiplatelet therapy; aspirin; clopidogrel; coronary artery bypass grafting; CABG; coronary artery bypass surgery; CI; confidence interval; DAPT; dual antiplatelet therapy; HR; hazard ratio; MI; myocardial infarction; NSAID; nonsteroidal anti-inflammatory
Keywords: مهار کننده پمپ پروتون; Allergy; immunology; innate; inflammation; food allergy; asthma; mast cell; eosinophil; ozone; IL-33; extracellular vesicles; AERD; Aspirin-exacerbated respiratory disease; CRTH2; Chemoattractant receptor-homologous molecule expressed on TH2 cells; DP1;
Keywords: مهار کننده پمپ پروتون; esomeprazole; frequent heartburn; gastroesophageal reflux; over-the-counter; proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; WHO; World Health Organization; API; active pharmaceutical ingredient; FDA; US Food and Drug Administration; RH; relative humidity; HCl; hydrochloride; PPI; proton pump inhibitor; NaCMC; croscarmellose sodium; ssNMR; solid state nuclear magnetic resonance
Keywords: مهار کننده پمپ پروتون; ADME-Tox; absorption, distribution, metabolism, excretion, and toxicity; AUC; area under the curve; BnSH; benzyl mercaptan; Xantphos; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; CYP2C19; hepatic cytochrome P450 2C19; CYP3A4; hepatic cytochrome P450 3
Keywords: مهار کننده پمپ پروتون; ACG; American College of Gastroenterology; AGA; American Gastroenterological Association; ASGE; American Society for Gastrointestinal Endoscopy; BE; Barrett's esophagus; EAC; esophageal adenocarcinoma; ESD; endoscopic submucosal dissection; HD-WLE; high
Keywords: مهار کننده پمپ پروتون; aspiration; asthma; inflammation; reflux; ACQ-7; Asthma Control Questionnaire 7; CF; cystic fibrosis; ELISA; enzyme-linked immunosorbent assay; GER; gastro-esophageal reflux; PPI; proton pump inhibitor;
Keywords: مهار کننده پمپ پروتون; Acid Suppression; Cognitive Dysfunction; Gut Microbiota; Liver Failure; cDDD; cumulative defined daily dose; CI; confidence interval; DDD; defined daily dose; GI; gastrointestinal; HE; hepatic encephalopathy; ICD-9-CM; International Classification of Dise
Keywords: مهار کننده پمپ پروتون; 6-MAM; 6-monoacetylmorphine; CNS; central nervous system; DMAA; dimethylamylamine; EtG; ethyglucuronide; ELISA; enzyme-linked immunosorbent assay; FDA; Food and Drug Administration; GC-MS; gas chromatography/mass spectrometry; LC-MS/MS; liquid chromatogra